Authors:
Babu, GJ
Loukianov, E
Loukianova, T
Pyne, GJ
Huke, S
Osol, G
Low, RB
Paul, RJ
Periasamy, M
Citation: Gj. Babu et al., Loss of SM-B myosin affects muscle shortening velocity and maximal force development, NAT CELL BI, 3(11), 2001, pp. 1025-1029
Citation: M. Periasamy et S. Huke, SERCA pump level is a critical determinant of Ca2+ homeostasis and cardiaccontractility, J MOL CEL C, 33(6), 2001, pp. 1053-1063
Authors:
Boknik, P
Vahlensieck, U
Huke, S
Knapp, J
Linck, B
Luss, H
Muller, FU
Neumann, J
Schmitz, W
Citation: P. Boknik et al., On the cardiac contractile, electrophysiological and biochemical effects of endothall, a protein phosphatase inhibitor, PHARMACOL, 61(1), 2000, pp. 43-50
Authors:
Linck, B
Boknik, P
Huke, S
Kirchhefer, U
Knapp, J
Luss, H
Muller, FU
Neumann, J
Tanriseven, Z
Vahlensieck, U
Baba, HA
Jones, LR
Philipson, KD
Schmitz, W
Citation: B. Linck et al., Functional properties of transgenic mouse hearts overexpressing both calsequestrin and the Na+-Ca2+ exchanger, J PHARM EXP, 294(2), 2000, pp. 648-657
Authors:
Knapp, J
Boknik, P
Deng, MC
Huke, S
Luss, I
Klein-Wiele, O
Linck, B
Luss, H
Muller, FU
Nacke, P
Scheld, HH
Schmitz, W
Vahlensieck, U
Neumann, J
Citation: J. Knapp et al., On the contractile function of protein phosphatases in isolated human coronary arteries, N-S ARCH PH, 360(4), 1999, pp. 464-472
Authors:
Knapp, J
Boknik, P
Luss, I
Huke, S
Linck, B
Luss, H
Muller, FU
Muller, T
Nacke, P
Noll, T
Piper, HM
Schmitz, W
Vahlensieck, U
Neumann, J
Citation: J. Knapp et al., The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability, J PHARM EXP, 289(3), 1999, pp. 1480-1486
Authors:
Vahlensieck, U
Boknik, P
Gombosova, I
Huke, S
Knapp, J
Linck, B
Luss, H
Muller, FU
Neumann, J
Deng, MC
Scheld, HH
Jankowski, H
Schluter, H
Zidek, W
Zimmermann, N
Schmitz, W
Citation: U. Vahlensieck et al., Inotropic effects of diadenosine tetraphosphate (AP(4)A) in human and animal cardiac preparations, J PHARM EXP, 288(2), 1999, pp. 805-813